Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Selection of antigenically advanced variants of seasonal influenza viruses.

Li C, Hatta M, Burke DF, Ping J, Zhang Y, Ozawa M, Taft AS, Das SC, Hanson AP, Song J, Imai M, Wilker PR, Watanabe T, Watanabe S, Ito M, Iwatsuki-Horimoto K, Russell CA, James SL, Skepner E, Maher EA, Neumann G, Klimov AI, Kelso A, McCauley J, Wang D, Shu Y, Odagiri T, Tashiro M, Xu X, Wentworth DE, Katz JM, Cox NJ, Smith DJ, Kawaoka Y.

Nat Microbiol. 2016 May 23;1(6):16058. doi: 10.1038/nmicrobiol.2016.58.

2.

Versatile synthesis of PHMB-stabilized silver nanoparticles and their significant stimulating effect on fodder beet (Beta vulgaris L.).

Gusev AА, Kudrinsky AA, Zakharova OV, Klimov AI, Zherebin PM, Lisichkin GV, Vasyukova IA, Denisov AN, Krutyakov YA.

Mater Sci Eng C Mater Biol Appl. 2016 May;62:152-9. doi: 10.1016/j.msec.2016.01.040. Epub 2016 Jan 21.

PMID:
26952409
3.

Rapid strategy for screening by pyrosequencing of influenza virus reassortants--candidates for live attenuated vaccines.

Shcherbik SV, Pearce NC, Levine ML, Klimov AI, Villanueva JM, Bousse TL.

PLoS One. 2014 Mar 19;9(3):e92580. doi: 10.1371/journal.pone.0092580. eCollection 2014.

4.

Structural stability of influenza A(H1N1)pdm09 virus hemagglutinins.

Yang H, Chang JC, Guo Z, Carney PJ, Shore DA, Donis RO, Cox NJ, Villanueva JM, Klimov AI, Stevens J.

J Virol. 2014 May;88(9):4828-38. doi: 10.1128/JVI.02278-13. Epub 2014 Feb 12.

5.

Antiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011.

Nguyen HT, Nguyen T, Mishin VP, Sleeman K, Balish A, Jones J, Creanga A, Marjuki H, Uyeki TM, Nguyen DH, Nguyen DT, Do HT, Klimov AI, Davis CT, Gubareva LV.

Emerg Infect Dis. 2013 Dec;19(12):1963-71. doi: 10.3201/eid1912.130705.

6.

Structural and antigenic variation among diverse clade 2 H5N1 viruses.

Shore DA, Yang H, Balish AL, Shepard SS, Carney PJ, Chang JC, Davis CT, Donis RO, Villanueva JM, Klimov AI, Stevens J.

PLoS One. 2013 Sep 27;8(9):e75209. doi: 10.1371/journal.pone.0075209. eCollection 2013.

7.

Influenza: propagation, quantification, and storage.

Balish AL, Katz JM, Klimov AI.

Curr Protoc Microbiol. 2013;Chapter 15:Unit 15G.1. doi: 10.1002/9780471729259.mc15g01s29.

PMID:
23686827
8.

Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.

Okomo-Adhiambo M, Sleeman K, Lysén C, Nguyen HT, Xu X, Li Y, Klimov AI, Gubareva LV.

Influenza Other Respir Viruses. 2013 Sep;7(5):645-58. doi: 10.1111/irv.12113. Epub 2013 Apr 10.

9.

Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.

Wang D, Sleeman K, Huang W, Nguyen HT, Levine M, Cheng Y, Li X, Tan M, Xing X, Xu X, Klimov AI, Gubareva LV, Shu Y.

Antiviral Res. 2013 Mar;97(3):240-4. doi: 10.1016/j.antiviral.2012.12.013. Epub 2012 Dec 23.

PMID:
23267831
10.

Microevolution of highly pathogenic avian influenza A(H5N1) viruses isolated from humans, Egypt, 2007-2011.

Younan M, Poh MK, Elassal E, Davis T, Rivailler P, Balish AL, Simpson N, Jones J, Deyde V, Loughlin R, Perry I, Gubareva L, ElBadry MA, Truelove S, Gaynor AM, Mohareb E, Amin M, Cornelius C, Pimentel G, Earhart K, Naguib A, Abdelghani AS, Refaey S, Klimov AI, Donis RO, Kandeel A.

Emerg Infect Dis. 2013 Jan;19(1):43-50. doi: 10.3201/eid1901.121080.

11.

WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.

Klimov AI, Garten R, Russell C, Barr IG, Besselaar TG, Daniels R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, McCauley J, Odagiri T, Smith D, Tashiro M, Xu X, Webby R, Wang D, Ye Z, Yuelong S, Zhang W, Cox N; Writing Committee of the World Health Organization Consultation on Southern Hemisphere Influenza Vaccine Composition for 2012.

Vaccine. 2012 Oct 5;30(45):6461-71. doi: 10.1016/j.vaccine.2012.07.089. Epub 2012 Aug 20.

12.

Seasonality, timing, and climate drivers of influenza activity worldwide.

Azziz Baumgartner E, Dao CN, Nasreen S, Bhuiyan MU, Mah-E-Muneer S, Al Mamun A, Sharker MA, Zaman RU, Cheng PY, Klimov AI, Widdowson MA, Uyeki TM, Luby SP, Mounts A, Bresee J.

J Infect Dis. 2012 Sep 15;206(6):838-46. doi: 10.1093/infdis/jis467. Epub 2012 Jul 24.

PMID:
22829641
13.

Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.

Nguyen HT, Trujillo AA, Sheu TG, Levine M, Mishin VP, Shaw M, Ades EW, Klimov AI, Fry AM, Gubareva LV.

Antiviral Res. 2012 Mar;93(3):381-6. doi: 10.1016/j.antiviral.2012.01.006. Epub 2012 Feb 7.

PMID:
22330888
14.

Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses.

Sandbulte MR, Westgeest KB, Gao J, Xu X, Klimov AI, Russell CA, Burke DF, Smith DJ, Fouchier RA, Eichelberger MC.

Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20748-53. doi: 10.1073/pnas.1113801108. Epub 2011 Dec 5.

15.

Clinical and virologic outcomes in patients with oseltamivir-resistant seasonal influenza A (H1N1) infections: results from a clinical trial.

Dharan NJ, Fry AM, Kieke BA, Coleman L, Meece J, Vandermause M, Gubareva LV, Klimov AI, Belongia EA.

Influenza Other Respir Viruses. 2012 May;6(3):153-8. doi: 10.1111/j.1750-2659.2011.00312.x. Epub 2011 Nov 26.

16.

Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective.

Okomo-Adhiambo M, Sleeman K, Ballenger K, Nguyen HT, Mishin VP, Sheu TG, Smagala J, Li Y, Klimov AI, Gubareva LV.

Viruses. 2010 Oct;2(10):2269-89. doi: 10.3390/v2102269. Epub 2010 Oct 13. Erratum in: Viruses. 2011 Aug;3(8):1415-6.

17.

Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets.

Gustin KM, Maines TR, Belser JA, van Hoeven N, Lu X, Dong L, Isakova-Sivak I, Chen LM, Voeten JT, Heldens JG, van den Bosch H, Cox NJ, Tumpey TM, Klimov AI, Rudenko L, Donis RO, Katz JM.

J Infect Dis. 2011 Nov 15;204(10):1491-9. doi: 10.1093/infdis/jir596. Epub 2011 Sep 28.

PMID:
21957153
18.

Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).

Gambaryan AS, Lomakina NF, Boravleva EY, Kropotkina EA, Mashin VV, Krasilnikov IV, Klimov AI, Rudenko LG.

Influenza Other Respir Viruses. 2012 May;6(3):188-95. doi: 10.1111/j.1750-2659.2011.00291.x. Epub 2011 Sep 23.

19.

Swine influenza virus A (H3N2) infection in human, Kansas, USA, 2009.

Cox CM, Neises D, Garten RJ, Bryant B, Hesse RA, Anderson GA, Trevino-Garrison I, Shu B, Lindstrom S, Klimov AI, Finelli L.

Emerg Infect Dis. 2011 Jun;17(6):1143-4. doi: 10.3201/eid/1706.101488. No abstract available.

20.

Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response.

Jernigan DB, Lindstrom SL, Johnson JR, Miller JD, Hoelscher M, Humes R, Shively R, Brammer L, Burke SA, Villanueva JM, Balish A, Uyeki T, Mustaquim D, Bishop A, Handsfield JH, Astles R, Xu X, Klimov AI, Cox NJ, Shaw MW.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S36-43. doi: 10.1093/cid/ciq020.

PMID:
21342897
21.

Diagnosis of influenza from respiratory autopsy tissues: detection of virus by real-time reverse transcription-PCR in 222 cases.

Denison AM, Blau DM, Jost HA, Jones T, Rollin D, Gao R, Liu L, Bhatnagar J, Deleon-Carnes M, Shieh WJ, Paddock CD, Drew C, Adem P, Emery SL, Shu B, Wu KH, Batten B, Greer PW, Smith CS, Bartlett J, Montague JL, Patel M, Xu X, Lindstrom S, Klimov AI, Zaki SR.

J Mol Diagn. 2011 Mar;13(2):123-8. doi: 10.1016/j.jmoldx.2010.09.004.

22.

Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.

Gubareva LV, Trujillo AA, Okomo-Adhiambo M, Mishin VP, Deyde VM, Sleeman K, Nguyen HT, Sheu TG, Garten RJ, Shaw MW, Fry AM, Klimov AI.

Antivir Ther. 2010;15(8):1151-9. doi: 10.3851/IMP1678.

PMID:
21149922
23.

Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010.

Sheu TG, Fry AM, Garten RJ, Deyde VM, Shwe T, Bullion L, Peebles PJ, Li Y, Klimov AI, Gubareva LV.

J Infect Dis. 2011 Jan 1;203(1):13-7. doi: 10.1093/infdis/jiq005.

24.

Genomic signature-based identification of influenza A viruses using RT-PCR/electro-spray ionization mass spectrometry (ESI-MS) technology.

Deyde VM, Sampath R, Garten RJ, Blair PJ, Myers CA, Massire C, Matthews H, Svoboda P, Reed MS, Pohl J, Klimov AI, Gubareva LV.

PLoS One. 2010 Oct 12;5(10):e13293. doi: 10.1371/journal.pone.0013293.

25.

Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivir.

Nguyen HT, Fry AM, Loveless PA, Klimov AI, Gubareva LV.

Clin Infect Dis. 2010 Oct 15;51(8):983-4. doi: 10.1086/656439. No abstract available.

PMID:
20858074
26.

Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.

Nguyen HT, Sheu TG, Mishin VP, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 Sep;54(9):3671-7. doi: 10.1128/AAC.00581-10. Epub 2010 Jun 28.

27.

Antigenic and genetic diversity of highly pathogenic avian influenza A (H5N1) viruses isolated in Egypt.

Balish AL, Davis CT, Saad MD, El-Sayed N, Esmat H, Tjaden JA, Earhart KC, Ahmed LE, Abd El-Halem M, Ali AH, Nassif SA, El-Ebiary EA, Taha M, Aly MM, Arafa A, O'Neill E, Xiyan X, Cox NJ, Donis RO, Klimov AI.

Avian Dis. 2010 Mar;54(1 Suppl):329-34.

PMID:
20521654
28.

In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.

Sleeman K, Mishin VP, Deyde VM, Furuta Y, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 Jun;54(6):2517-24. doi: 10.1128/AAC.01739-09. Epub 2010 Mar 29.

29.

Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.

Okomo-Adhiambo M, Demmler-Harrison GJ, Deyde VM, Sheu TG, Xu X, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 May;54(5):1834-41. doi: 10.1128/AAC.01608-09. Epub 2010 Mar 1.

30.

Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.

Dharan NJ, Gubareva LV, Klimov AI, Fiore AE, Bresee JS, Fry AM.

Clin Infect Dis. 2010 Feb 15;50(4):621-2. doi: 10.1086/650178. No abstract available.

PMID:
20095841
31.

Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007-2008.

Zaman RU, Alamgir AS, Rahman M, Azziz-Baumgartner E, Gurley ES, Sharker MA, Brooks WA, Azim T, Fry AM, Lindstrom S, Gubareva LV, Xu X, Garten RJ, Hossain MJ, Khan SU, Faruque LI, Ameer SS, Klimov AI, Rahman M, Luby SP.

PLoS One. 2009 Dec 29;4(12):e8452. doi: 10.1371/journal.pone.0008452.

32.

Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.

Deyde VM, Sheu TG, Trujillo AA, Okomo-Adhiambo M, Garten R, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 Mar;54(3):1102-10. doi: 10.1128/AAC.01417-09. Epub 2009 Dec 22.

33.

Outbreak of antiviral drug-resistant influenza a in long-term care facility, Illinois, USA, 2008.

Dharan NJ, Patton M, Siston AM, Morita J, Ramirez E, Wallis TR, Deyde V, Gubareva LV, Klimov AI, Bresee JS, Fry AM.

Emerg Infect Dis. 2009 Dec;15(12):1973-6. doi: 10.3201/eid1512.081644.

34.

Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.

Okomo-Adhiambo M, Nguyen HT, Sleeman K, Sheu TG, Deyde VM, Garten RJ, Xu X, Shaw MW, Klimov AI, Gubareva LV.

Antiviral Res. 2010 Feb;85(2):381-8. doi: 10.1016/j.antiviral.2009.11.005. Epub 2009 Nov 13.

PMID:
19917319
35.

Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein.

Triana-Baltzer GB, Gubareva LV, Klimov AI, Wurtman DF, Moss RB, Hedlund M, Larson JL, Belshe RB, Fang F.

PLoS One. 2009 Nov 6;4(11):e7838. doi: 10.1371/journal.pone.0007838.

36.

Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing.

Sheu TG, Deyde VM, Garten RJ, Klimov AI, Gubareva LV.

Antiviral Res. 2010 Feb;85(2):354-60. doi: 10.1016/j.antiviral.2009.10.022. Epub 2009 Nov 1.

PMID:
19887086
37.

Influenza epidemiology and characterization of influenza viruses in patients seeking treatment for acute fever in Cambodia.

Blair PJ, Wierzba TF, Touch S, Vonthanak S, Xu X, Garten RJ, Okomo-Adhiambo MA, Klimov AI, Kasper MR, Putnam SD.

Epidemiol Infect. 2010 Feb;138(2):199-209. doi: 10.1017/S095026880999063X. Epub 2009 Aug 24.

PMID:
19698213
38.

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ.

Science. 2009 Jul 10;325(5937):197-201. doi: 10.1126/science.1176225. Epub 2009 May 22.

39.

Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay.

Guo L, Garten RJ, Foust AS, Sessions WM, Okomo-Adhiambo M, Gubareva LV, Klimov AI, Xu X.

Antiviral Res. 2009 Apr;82(1):29-33. doi: 10.1016/j.antiviral.2009.01.004. Epub 2009 Jan 31.

PMID:
19428592
40.

Characterization of a highly pathogenic avian influenza H5N1 virus sublineage in poultry seized at ports of entry into Vietnam.

Nguyen T, Davis CT, Stembridge W, Shu B, Balish A, Inui K, Do HT, Ngo HT, Wan XF, McCarron M, Lindstrom SE, Cox NJ, Nguyen CV, Klimov AI, Donis RO.

Virology. 2009 May 10;387(2):250-6. doi: 10.1016/j.virol.2009.03.006. Epub 2009 Apr 2.

41.

[Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3].

Desheva IuA, Smolonogina TA, Sergeeva MV, Rekstin AR, Swayne D, Klimov AI, Rudenko LG.

Zh Mikrobiol Epidemiol Immunobiol. 2009 Jan-Feb;(1):31-6. Russian.

PMID:
19340965
42.

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St George K, Epperson S, Brammer L, Klimov AI, Bresee JS, Fry AM; Oseltamivir-Resistance Working Group.

JAMA. 2009 Mar 11;301(10):1034-41. doi: 10.1001/jama.2009.294. Epub 2009 Mar 2.

PMID:
19255110
43.

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.

Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ.

Vaccine. 2008 Sep 12;26 Suppl 4:D31-4. Review.

PMID:
19230156
44.

Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.

Deyde VM, Nguyen T, Bright RA, Balish A, Shu B, Lindstrom S, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2009 Mar;53(3):1039-47. doi: 10.1128/AAC.01446-08. Epub 2009 Jan 5.

45.

Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.

Deyde VM, Okomo-Adhiambo M, Sheu TG, Wallis TR, Fry A, Dharan N, Klimov AI, Gubareva LV.

Antiviral Res. 2009 Jan;81(1):16-24. doi: 10.1016/j.antiviral.2008.08.008. Epub 2008 Oct 7.

PMID:
18835410
46.

6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry.

Gambaryan AS, Tuzikov AB, Pazynina GV, Desheva JA, Bovin NV, Matrosovich MN, Klimov AI.

Virol J. 2008 Jul 24;5:85. doi: 10.1186/1743-422X-5-85.

47.

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92. doi: 10.1128/AAC.00555-08. Epub 2008 Jul 14.

48.

The global circulation of seasonal influenza A (H3N2) viruses.

Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ.

Science. 2008 Apr 18;320(5874):340-6. doi: 10.1126/science.1154137.

49.

Detection of adamantane-resistant influenza on a microarray.

Townsend MB, Smagala JA, Dawson ED, Deyde V, Gubareva L, Klimov AI, Kuchta RD, Rowlen KL.

J Clin Virol. 2008 Jun;42(2):117-23. doi: 10.1016/j.jcv.2007.12.019. Epub 2008 Mar 4.

50.

Adamantane-resistant influenza infection during the 2004-05 season.

Rahman M, Bright RA, Kieke BA, Donahue JG, Greenlee RT, Vandermause M, Balish A, Foust A, Cox NJ, Klimov AI, Shay DK, Belongia EA.

Emerg Infect Dis. 2008 Jan;14(1):173-6. doi: 10.3201/eid1401.070460.

Supplemental Content

Loading ...
Support Center